Moyamoya Disease and Stroke in Children

What is Moyamoya Disease?
Is there any treatment?
What research is being done?

Journal Articles

HomeCause of Stroke in Children > Moya Moya Disease

Site Map

Contact Us

What is Moyamoya Disease?
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of major blood vessels leading into the brain, and the formation of abnormal blood vessels called moyamoya vessels. First described in Japan in the 1960s, the disease has since been found in the United States, Europe, Australia, and Africa. It primarily affects children, adolescents, and young adults, although it has also been seen in people beyond these ages. Females are more frequently affected than males. The cause of the disease is unknown. Researchers suspect a genetic link because of the high incidence of the disease found in certain Japanese families. The name "moyamoya" is Japanese for "cloud of smoke" and was chosen to describe the classic appearance of the abnormal vessels seen in diagnostic tests. Children often present with stroke or recurrent transient ischemic attacks (TIAs), frequently accompanied by hemiparesis (muscular weakness or paralysis affecting one side of the body) or seizures. Adults most often experience stroke (often a hemorrhage). Both children and adults may have disturbed consciousness, speech deficits (aphasia), sensory and cognitive impairments, involuntary movements, and vision problems. Generally, cerebral angiography - a procedure that involves injecting dye into the cerebral arteries before taking an x-ray to make the arteries easier to see - is used to diagnose moyamoya disease.

Is there any treatment?
There is no cure for moyamoya disease. Treatment is symptomatic and supportive. Individuals experiencing TIAs and stroke may be given aspirin, vasodilators, or anticoagulants to reduce the risk of future attacks. There are several different types of revascularization (restoration of blood supply) surgery that may be performed in some cases. Children usually respond better to revascularization surgery than adults.

What research is being done?
Within the NINDS research programs, moyamoya disease is addressed primarily through studies associated with TIA and stroke. NINDS is the leading supporter of research on stroke and TIA in the United States and sponsors studies ranging from clinical trials to investigations of basic biological mechanisms.

This article reprinted with permission from the National Institute of Neurological Disorders and Stroke.

Journal Articles

Moyamoya Columbia Presbyterian Medical Center

Moyamoya Disease UCLA Neurosurgery Department

Moya Moya Disease Chicago Institute of Neurosurgery and Neuroresearch

Arterio-embolic ischemic stroke in children with moyamoya disease. May 2004. Germany

Long-term effects of indirect bypass surgery on collateral vessel formation in pediatric moyamoya disease  Feb. 2004. Japan

Clinical manifestations of infantile moyamoya disease. Oct. 2003. Japan

Surgical treatment of moyamoya disease in pediatric age 2001

Combined encephaloduroarteriosynangiosis and bifrontal
encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease
Jan. 2002

Direct and combined revascularization in pediatric moyamoya disease

Pediatric Aneurysms & Moyamoya Disease - Australia

Copyright 1997-2007, CHASA, All Rights Reserved

The information contained in this web site and on the Hemi-Kids listserv are not a substitute for medical advice or treatment, and the site owners recommend consultation with your doctor or health care professional.